Clinical Trial Update: HAIC in Combination with Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Advanced HCC

View source ↗

Summary

A clinical trial update describing a study of hepatic arterial infusion chemotherapy in combination with immune checkpoint inhibitors and tyrosine kinase inhibi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: First Hospital of China Medical University | Conditions: Hepatic Arterial Infusion Chemotherapy, Tyrosine Kinase Inhibitor | Status: ACTIVE_NOT_RECRUITING